Application of nanosized Fe 3 O 4 in anticancer drug carriers with target-orientation and sustained-release properties
- 3 May 2007
- journal article
- Published by IOP Publishing in Biomedical Materials
- Vol. 2 (2), 132-134
- https://doi.org/10.1088/1748-6041/2/2/011
Abstract
The purpose of this study was to prepare human serum albumin (HSA) microspheres with Fe(3)O(4) magnetic nanoparticles for tumor target therapy. Fe(3)O(4) was obtained by liquid-phase coprecipitation; HSA-coated magnetic particles were attained by solidification at high temperature. The result was that nanosized Fe(3)O(4) is a cubic crystal by XRD and the average size is 18.7 nm; the average size of HSA-coated magnetic particles is 341 nm. Fe(3)O(4) magnetic nanoparticles coated with HSA can be used for targeted-drug carriers with target-orientation and sustained-release properties.Keywords
This publication has 3 references indexed in Scilit:
- Preparation and characterization of core-shell monodispersed magnetic silica microspheresColloids and Surfaces A: Physicochemical and Engineering Aspects, 2003
- Modifying the Surface Properties of Superparamagnetic Iron Oxide Nanoparticles through A Sol−Gel ApproachNano Letters, 2002
- Chemical Reactions in Microemulsions: A Powerful Method to Obtain Ultrafine ParticlesJournal of Colloid and Interface Science, 1993